PROFUSA, INC. Gain (Loss) on Extinguishment of Debt
PROFUSA, INC. (PFSA) reported Gain (Loss) on Extinguishment of Debt of $1.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-19
- PROFUSA, INC. gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was -$1.00K.
- PROFUSA, INC. gain (loss) on extinguishment of debt for the quarter ending 2026-03-31 was $1.39M.
- PROFUSA, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was -$3.33M, a 2967.24% decline year-over-year.
- PROFUSA, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $258.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $1.39M 10-Q · filed 2026-08-19 | -$1.94M derived: sum of 3 quarters · filed 2026-08-19 | -$1.68M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $1.39M 10-Q · filed 2026-05-15 | -$1.93M derived: sum of 2 quarters · filed 2026-05-15 | -$1.68M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | -$3.33M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | -$3.07M derived: sum of 2 quarters · filed 2026-05-01 | -$3.38M S-1/A · filed 2026-05-01 | |
| 2025-09-30 | $258.00K 10-Q · filed 2025-11-19 | -$52.00K 10-Q · filed 2025-11-19 | ||
| 2024-12-31 | $116.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | -$204.00K derived: sum of 2 quarters · filed 2026-05-01 | -$311.00K S-1/A · filed 2026-05-01 | |
| 2024-09-30 | -$320.00K 10-Q · filed 2025-11-19 | -$427.00K 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |